Geographic disparities in peripartum cardiomyopathy outcomes

Lindsay S Robbins1, Jeff M Szychowski2, Ariann Nassel3

  • 1Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA (Dr Robbins); Center for Maternal and Child Health Equity and Advocacy, Eastern Virginia Medical School Norfolk, VA (Dr Robbins).

Insights

Severe peripartum cardiomyopathy is linked to higher social vulnerability in communities. Addressing social determinants of health in these areas is crucial for reducing maternal mortality and disparities.

Area of Science:

  • Cardiology
  • Public Health
  • Social Epidemiology

Background:

  • Peripartum cardiomyopathy is a significant cause of pregnancy-related deaths.
  • Racial disparities exist in outcomes for pregnant individuals with cardiomyopathy.
  • Community factors may underlie these disparities in peripartum cardiomyopathy outcomes.

Purpose of the Study:

  • To investigate the geographic distribution of peripartum cardiomyopathy outcomes.
  • To identify disparities in peripartum cardiomyopathy outcomes.
  • To test the hypothesis that higher community social vulnerability correlates with worse peripartum cardiomyopathy outcomes.

Main Methods:

  • Retrospective cohort study of peripartum cardiomyopathy patients (2000-2017).
  • Defined severe peripartum cardiomyopathy by ejection fraction <30%, death, ICU admission, device placement, or transplant.
  • Linked patient census tracts to the CDC Social Vulnerability Index.

Main Results:

  • Patients with severe peripartum cardiomyopathy were more likely to be Black and less likely to recover ejection fraction.
  • Severe peripartum cardiomyopathy patients resided in areas with higher Social Vulnerability Index scores.
  • Communities of severe peripartum cardiomyopathy patients had higher unemployment, poverty, and minority status.

Conclusions:

  • Higher social vulnerability in communities is associated with severe peripartum cardiomyopathy outcomes.
  • Targeting resources to socially vulnerable communities may reduce disparities and maternal mortality.
Abstract

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
20
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
41
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
27